-
Hormone therapy, also called androgen deprivation therapy or androgen suppression therapy, reduces androgen levels to prevent these hormones from reaching prostate cancer cells.
-
If the prostate-specific antigen (PSA) level shows that the prostate cancer has not been cured after an initial attempt, further treatment may be an option.
-
Research Scholar Grant (RSG)
Grant No. Investigator/Mentor/Institution Title Grant Term Grant Awarded
RSG-13-021-01 Arnold, Connie L., PhD
LSU Health Sciences Center in Shreveport
Department of General Internal Medicine
Shreveport, LA
Health Literacy...
-
Hormone therapy is the center of care for prostate cancer but eventually stops working for some men. An American Cancer Society grantee is investigating why this happens and what he's learning could lead to better treatments for men with advanced prostate cancer.
-
The US Food and Drug Administration (FDA) has approved Erleada (apalutamide) to treat men with non-metastatic castration-resistant prostate cancer.
-
The following sources were used in preparing our information about prostate cancer.
-
Treating Prostate Cancer
If you've been diagnosed with prostate cancer, your cancer care team will discuss your
treatment options with you. It's important to weigh the benefits of each treatment option
against the possible risks and side effects.
Ho...
-
Men being treated for early-stage prostate cancer with external beam radiation therapy (EBRT) can safely choose an option that reduces the number of treatment sessions, according to a panel of experts from the American Society for Radiation Oncology, American Society of Clinical Oncology, and American Urological Association.
-
Skip to Content
Menu
Search
...
-
Nuestro equipo de periodismo profesional pone a su disposición diversos artículos relacionados al cáncer desde todos los ángulos.